Integrated Drug Discovery CRO Services for Pharmaceutical R&D
ChemDiv is a recognized global leader in drug discovery solutions. We offer fully integrated R&D Services to support pharmaceutical R&D projects.
Over the past 29 years ChemDiv has delivered hundreds of leads, drug candidates and new drugs in the area of CNS, Oncology, virology, inflammation, cardiometabolic and immunology, to pharma, biotech and academic partners around the globe.
Benefit from ChemDiv’s flexible CRO as a one-stop and cost-effective solution.
Focused and targeted libraries
114 predesigned screening libraries. Introduced by therapeutical areas, targets and mechanism of action.
Active Reference Sets
17 annotated libraries. Over 220,000 compounds with available bioactivity data, >25,000 targets, >1,000,000 activity data points across various areas.
Diversity libraries
Representative diversity sets cover space of billions compounds. 2D and 3D.
Building blocks
Search and purchase
Substructure Search for Screening Compounds
Search and purchase in the largest commercially available space. Regular new arrivals.
Download full database
Popular
Targeted Diversity Library
39,646 compounds
3D-Pharmacophore Based Diversity Library
52,000 compounds
Representative Diversity Libraries
50,000 / 100,000 / 150,000 compounds
Cardiovascular Library
22,203 compounds
Antiviral Library
65,937 compounds
miRNA targeted small molecule library
20,000 compounds
CNS MPO Library
28,284 compounds
CNS BBB Library
22,790 compounds
Integrated drug discovery services
In silico drug design (CADD)
Discovery biology
Medicinal chemistry
Join ChemDiv,Inc at the International Helmholtz Drug Discovery Conference (HDDC)
Join ChemDiv,Inc at the International Helmholtz Drug Discovery Conference (HDDC) 2023 that will take place in Germany www.helmholtz-hzi.de/de/hddc2023 (May 15 to 16, 2023 – Braunschweig, Germany...
Novel inhibitors of ovarian cancer from ChemDiv collection
Yueyan Li, Xuan Huang, Jing Tang from Fudan University, Shanghai reported rational design and discovery of novel small molecule inhibitors of ovarian cancer, targeting La-RNA interactions in collabora...
ChemDiv Company in publications and patents
We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.
It means a lot to us if our custome...
FDA warns vs fake versions of popular medicines
MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported.
...
Science & Nature Reviews, February 2022. Part II
Neurophysiology
Kelava, I., Chiaradia, I., Pellegrini, L. et al. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112–116 (2022)
Sex-based brain dif...
Beyond binary: scaled molecular fingerprints for maximum diversity picking
PROTACs